Stabilized Menthol Cannabinoid Gum via Undecylenic Acid
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a need for effective delivery methods of cannabinoids and menthol that maintain their activity when incorporated into chewing gum or lozenges, addressing the inefficacy of current pain and inflammation treatments and the concern over opioid overuse.
Innovation Solution
A chewing gum or lozenge product containing cannabinoids and menthol, with a stabilized menthol composition using undecylenic acid methyl ester, undecylenic acid, or their salts, providing a unit dose formulation that includes full spectrum hemp oil and menthol, ensuring effective oral administration.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If therapeutic compounds such as cannabinoids and menthol are incorporated into chewing gum or lozenges, then effective delivery to the user is achieved, but maintaining their activity becomes difficult
Solution Approach 1:
The patent employs encapsulation technologies and compatible carriers as intermediary substances to protect cannabinoids and menthol from degradation in the gum matrix. These intermediaries maintain the therapeutic compounds' activity while enabling their incorporation into the chewing gum or lozenge formulation.
Solution Approach 2:
The patent modifies physical and chemical parameters of the formulation, including pH control, oxidation prevention, and stability-enhancing additives, to maintain the therapeutic activity of cannabinoids and menthol throughout the product's shelf life and during use.
2Reliability
If current pain and inflammation treatments are used, then pain relief is achieved, but unacceptable side effects occur
Solution Approach 1:
The patent utilizes cannabinoids and menthol, which provide pain relief and anti-inflammatory effects through different mechanisms than traditional opioids, thereby achieving therapeutic efficacy with a more favorable side effect profile. The specific dosing ranges and formulation parameters are optimized to maximize benefit while minimizing adverse effects.
3Reliability
If opioids are used for pain treatment, then effective pain relief is achieved, but overuse concerns arise
Solution Approach 1:
The patent provides alternative pain management through cannabinoids and menthol formulations that can effectively treat pain without contributing to opioid overuse. The unit dose formulations enable precise control of therapeutic input, providing effective pain relief while avoiding the public health crisis associated with opioid dependency and overconsumption.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The product effectively delivers cannabinoids and menthol for pain relief and inflammation management, offering a novel treatment option with reduced side effects and avoiding opioid-related concerns.
Implementation Method 1
a stabilized menthol composition including menthol and at least one menthol stabilizer compound including undecylenic acid methyl ester, undecylenic acid or a salt of undecylenic acid
Data Source
AI summary
The present disclosure relates to chewing gum or lozenge with cannabinoids and menthol including a liquid-filled chewing gum or lozenge with a chewing gum base shell or lozenge candy shell enclosing an internal void therein and a liquid filling in the void, the liquid-filled chewing gum or lozenge including cannabinoids and menthol. The menthol component can be a stabilized menthol composition comprising menthol and at least one menthol stabilizer compound including undecylenic acid methyl ester, undecylenic acid or a salt of undecylenic acid.